Radiopharmaceuticals and Tracers

This channel includes news and new technology innovations for nuclear and molecular imaging agents, radiotracers and radiopharmaceuticals used in PET or SPECT imaging. This includes advances in myocardiac perfusion agents.

News | Radiopharmaceuticals and Tracers

January 17, 2017 — NorthStar Medical Technologies LLC has received additional matching funds from the U.S. Department of ...

Time January 17, 2017
arrow
News | Nuclear Imaging

January 12, 2017 — Bayer Healthcare has initiated a recall of all its Medrad Intego PET Infusion System Source ...

Time January 12, 2017
arrow
News | Radiopharmaceuticals and Tracers

January 6, 2017 — New research demonstrates that a novel imaging agent can quickly and accurately detect metastasis of ...

Time January 06, 2017
arrow
News | Radiation Therapy

January 3, 2017 — Sirtex Medical Limited announced in December that SIR-Spheres Y-90 resin microspheres have been ...

Time January 03, 2017
arrow
News

December 28, 2016 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has developed United States ...

Time December 28, 2016
arrow
News | Prostate Cancer

Cancer Targeted Technology (CTT), a privately-held Seattle-based biotechnology firm focusing on cancer diagnostics and ...

Time December 22, 2016
arrow
News | Prostate Cancer

December 14, 2016 — Cancer Targeted Technology (CTT), a privately-held Seattle-based biotechnology firm focusing on ...

Time December 14, 2016
arrow
News | Nuclear Imaging

Molecular Targeting Technologies, Inc. (MTTI) announces that response of colorectal cancer to treatment can be detected ...

Time December 12, 2016
arrow
News | Radiopharmaceuticals and Tracers

November 2, 2016 — By the time unambiguous signs of memory loss and cognitive decline appear in people with Alzheimer’s ...

Time November 02, 2016
arrow
News | Radiopharmaceuticals and Tracers

October 28, 2016 — The National Academies of Sciences, Engineering, and Medicine (NAS) have released a report on the ...

Time October 28, 2016
arrow
News | Prostate Cancer

October 25, 2016 — Blue Earth Diagnostics Ltd. announced the peer-reviewed publication of results from a Phase 3 ...

Time October 25, 2016
arrow
News | Radiopharmaceuticals and Tracers

October 17, 2016 — Lantheus Holdings Inc. announced in late September that sub-analysis data from the first Phase 3 ...

Time October 17, 2016
arrow
Feature | Neuro Imaging

September 9, 2016 — The Alzheimer’s Disease Neuroimaging Initiative (ADNI) recently launched into its next phase, ADNI3 ...

Time September 09, 2016
arrow
News | Radiopharmaceuticals and Tracers

September 7, 2016 — Blue Earth Diagnostics announced that the first post-U.S. Food and Drug Administration (FDA) ...

Time September 07, 2016
arrow
News | Radiopharmaceuticals and Tracers

September 6, 2016 — Navidea Biopharmaceuticals Inc. announced that it has executed a Letter of Intent (LOI) with ...

Time September 06, 2016
arrow
News | PET Imaging

September 1, 2016 — The American Society for Nuclear Cardiology (ASNC) and the Society of Nuclear Medicine and Molecular ...

Time September 01, 2016
arrow
News | Radiopharmaceuticals and Tracers

July 12, 2016 — Lantheus Holdings Inc., the parent company of Lantheus Medical Imaging Inc. (LMI), announced the first ...

Time July 12, 2016
arrow
News | Radiopharmaceuticals and Tracers

July 7, 2016 — Cell>Point announced in mid-June it has entered into an exclusive license agreement for China, Hong Kong ...

Time July 07, 2016
arrow
News | Radiopharmaceuticals and Tracers

July 6, 2016 — Navidea Biopharmaceuticals Inc. announced results from three investigator-initiated studies of the ...

Time July 06, 2016
arrow
News | Oncology Diagnostics

June 23, 2016 — Malignant neuroendocrine tumors (NETs) are relatively rare, notoriously difficult to treat, and ...

Time June 23, 2016
arrow
Subscribe Now